AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment

AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment

Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease.

Visit NPUb.org/Podcast for associated article links.

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1371)

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.  For more information, please read about the abstract that was ...

27 Jul 26min

2026 International Conference on Functional Neurological Disorder

2026 International Conference on Functional Neurological Disorder

Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's...

23 Jul 24min

Exploring Military Sexual Trauma and Migraine Among US Veterans

Exploring Military Sexual Trauma and Migraine Among US Veterans

Dr. Stacey Clardy talks with Dr. John Ney about the link between military sexual trauma and migraine among US veterans.  Read the related article in Neurology® Clinical Practice.  Disclosures can be f...

20 Jul 22min

Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants

Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants

Dr. Derek Stitt talks with Dr. Jennifer Morganroth about the evolving landscape of genetic testing in ALS, the importance of longitudinal care for at-risk individuals, and the capacity challenges face...

16 Jul 14min

When Drug Marketing Masquerades as Clinical Trials

When Drug Marketing Masquerades as Clinical Trials

Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care.  Read the relat...

13 Jul 17min

Neurology® at 75: The Evolution of the Neurology Journal

Neurology® at 75: The Evolution of the Neurology Journal

To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®.  Read more about the first ...

9 Jul 30min

Navigating the Transition From Pediatric to Adult Epilepsy Care

Navigating the Transition From Pediatric to Adult Epilepsy Care

Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care.  Read the related article in Neurology® Clinical Practice.   Disclosures can be found a...

6 Jul 22min

Communication About Uncertainty During PD Diagnostic Consultations

Communication About Uncertainty During PD Diagnostic Consultations

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.  Read the rel...

2 Jul 16min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
forskningno
rekommandert
liberal-halvtime
jss
sinnsyn
villmarksliv
abels-tarn
fjellsportpodden
dekodet-2
rss-nysgjerrige-norge
tomprat-med-gunnar-tjomlid
hva-er-greia-med
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
grunnstoffene
mer-enn-hjerne
diagnose
kvinnehelsepodden